Strategy Inc.'s Variable Rate Series A Perpetual Stretch Preferred Stock (STRC) fell to an all-time low of $89 on June 17, 2026, trading about 11% below its $100 par value. This preferred stock, designed to fund Bitcoin purchases and pay variable dividends, now offers a yield near 12.9%, reflecting increased risk perception. The price drop paused the company's at-the-market offering program, raising concerns about a potential 'death spiral' where higher dividends to attract investors could strain cash and force asset sales. Strategy counters these worries by highlighting its liquidity, recent Bitcoin sales to cover dividends, and ongoing Bitcoin acquisitions funded by common stock sales. Market watchers will closely monitor if STRC stabilizes or requires dividend adjustments amid Bitcoin price volatility and investor sentiment shifts.
Two student entrepreneurs, Brandon Garcia and Abiha Haider, won the NFTE New York Metro Youth Entrepreneurship Showcase and will advance to the U.S. National Youth Entrepreneurship Showcase in New York City this fall. Brandon's business, ProspectPath...
Teamshares Inc. finalized its business combination with Live Oak Acquisition Corp. V after shareholder approval on June 16, 2026. The deal included a $126.5 million capital raise through a PIPE investment from institutional investors and Teamshares m...
Hengdian World Studios saw a major spike in visitors after the Chinese drama Pursuit of Jade, filmed mostly at the studio, topped international streaming charts and search volumes in 15 countries. During the May holiday, over 80,000 tourists visited ...
The global sputtering equipment market is projected to grow from USD 2.41 billion in 2025 to USD 4.19 billion by 2035, at a CAGR of 5.83%. Growth is fueled by rising demand for high-performance semiconductors, flat panel displays, and photovoltaic so...
Japan's Ministry of Health has approved Sanofi's Sarclisa (isatuximab) in a subcutaneous form for treating multiple myeloma, including newly diagnosed and relapsed/refractory cases. This approval follows positive results from the phase 3 IRAKLIA stud...
